All Stories

  1. Informing health system planning for biomarker-based treatment: statistical prevalence projections for solid cancers with key pan-tumour biomarkers (dMMR, MSI, high TMB) in Australia to 2042
  2. Using G-methods to assess and mitigate bias from coarsening time intervals in evaluating colorectal cancer screening efficiency
  3. Estimates of the eligible population for Australia’s targeted National Lung Cancer Screening Program, 2025-2030
  4. Public Preferences for Genetic and Genomic Risk-Informed Chronic Disease Screening and Early Detection: A Systematic Review of Discrete Choice Experiments
  5. Trends and projections of cause-specific premature mortality in Australia to 2044: a statistical modelling study
  6. Risk of COVID‐19 death for people with a pre‐existing cancer diagnosis prior to COVID‐19‐vaccination: A systematic review and meta‐analysis
  7. Health services costs for ovarian cancer in Australia: Estimates from the 45 and Up Study
  8. Female reproductive and hormonal factors and lung cancer mortality among never‐smokers: A prospective cohort study of 287 408 Chinese women
  9. Colon and rectal cancer treatment patterns and their associations with clinical, sociodemographic and lifestyle characteristics: analysis of the Australian 45 and Up Study cohort
  10. An ecological study of obesity-related cancer incidence trends in Australia from 1983 to 2017
  11. A scoping review and meta-analysis on the prevalence of pan-tumour biomarkers (dMMR, MSI, high TMB) in different solid tumours
  12. Solid Fuel, Secondhand Smoke, and Lung Cancer Mortality: A Prospective Cohort of 323,794 Chinese Never-Smokers
  13. Pathways to diagnosis of endometrial and ovarian cancer in the 45 and Up Study cohort
  14. Are patients with cancer at higher risk of COVID-19-related death? A systematic review and critical appraisal of the early evidence
  15. The risk of contracting SARS-CoV-2 or developing COVID-19 for people with cancer: A systematic review of the early evidence
  16. An epigenome-wide view of osteoarthritis in primary tissues
  17. Projections of smoking-related cancer mortality in Australia to 2044
  18. Cancer incidence and mortality in Australia from 2020 to 2044 and an exploratory analysis of the potential effect of treatment delays during the COVID-19 pandemic: a statistical modelling study
  19. Evaluating risk factors for lung cancer among never-smoking individuals using two Australian studies
  20. Family history, obesity, urological factors and diabetic medications and their associations with risk of prostate cancer diagnosis in a large prospective study
  21. Raking of data from a large Australian cohort study improves generalisability of estimates of prevalence of health and behaviour characteristics and cancer incidence
  22. Lynch syndrome testing of colorectal cancer patients in a high-income country with universal healthcare: a retrospective study of current practice and gaps in seven australian hospitals
  23. Tobacco smoking changes during the first pre-vaccination phases of the COVID-19 pandemic: A systematic review and meta-analysis
  24. Independent evaluation of melanoma polygenic risk scores in UK and Australian prospective cohorts*
  25. Trends in colon and rectal cancer mortality in Australia from 1972 to 2015 and associated projections to 2040
  26. Accurate categorisation of menopausal status for research studies: a step-by-step guide and detailed algorithm considering age, self-reported menopause and factors potentially masking the occurrence of menopause
  27. A molecular map of long non-coding RNA expression, isoform switching and alternative splicing in osteoarthritis
  28. 45 and Up COVID Insights: a dynamic and collaborative approach to evidence-making during the COVID-19 pandemic
  29. Capacity of the 45 and Up Study to mobilise evidence-based improvements in cancer control: lung cancer case study
  30. Health system costs and days in hospital for colorectal cancer patients in New South Wales, Australia
  31. Deciphering osteoarthritis genetics across 826,690 individuals from 9 populations
  32. Linking chondrocyte and synovial transcriptional profile to clinical phenotype in osteoarthritis
  33. Building capacity from within: qualitative evaluation of a training program aimed at upskilling healthcare workers in delivering an evidence-based implementation approach
  34. A molecular quantitative trait locus map for osteoarthritis
  35. Risk factors for lung cancer in never-smokers.
  36. How Well Have Projected Lung Cancer Rates Predicted the Actual Observed Rates?
  37. Large-scale systematic analysis of exposure to multiple cancer risk factors and the associations between exposure patterns and cancer incidence
  38. Accelerating functional gene discovery in osteoarthritis
  39. Lung cancer risk in never-smokers: An overview of environmental and genetic factors
  40. Changes in cancer incidence and mortality in Australia over the period 1996–2015
  41. Comparing theory and non-theory based implementation approaches to improving referral practices in cancer genetics: a cluster randomised trial protocol
  42. Towards global elimination of cervical cancer in all groups of women – Authors' reply
  43. Lung cancer mortality in Australia in the twenty-first century: How many lives can be saved with effective tobacco control?
  44. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020–99: a modelling study
  45. Identification of new therapeutic targets for osteoarthritis through genome-wide analyses of UK Biobank data
  46. Genome-wide association study of developmental dysplasia of the hip identifies an association with GDF5
  47. Widespread epigenomic, transcriptomic and proteomic differences between hip osteophytic and articular chondrocytes in osteoarthritis
  48. Genome-wide analyses using UK Biobank data provide insights into the genetic architecture of osteoarthritis
  49. A novel variant inGLIS3is associated with osteoarthritis
  50. Integrative epigenomics, transcriptomics and proteomics of patient chondrocytes reveal genes and pathways involved in osteoarthritis
  51. Investigation of common, low-frequency and rare genome-wide variation in anorexia nervosa
  52. Whole-Genome Sequencing Coupled to Imputation Discovers Genetic Signals for Anthropometric Traits
  53. Effects of chronic cobalt and chromium exposure after metal-on-metal hip resurfacing: An epigenome-wide association pilot study
  54. OUP accepted manuscript
  55. Functional genomics in osteoarthritis: Past, present, and future
  56. Haploinsufficiency predictions without study bias
  57. Gene Networks Underlying Convergent and Pleiotropic Phenotypes in a Large and Systematically-Phenotyped Cohort with Heterogeneous Developmental Disorders
  58. Duplications in ADHD patients harbour neurobehavioural genes that are co‐expressed with genes associated with hyperactivity in the mouse
  59. Gene Age Predicts the Strength of Purifying Selection Acting on Gene Expression Variation in Humans
  60. GeneNet Toolbox for MATLAB: a flexible platform for the analysis of gene connectivity in biological networks
  61. Summaries of oral sessions at the XXI World Congress of Psychiatric Genetics, Boston, Massachusetts, 17–21 October 2013
  62. Diagnostically relevant facial gestalt information from ordinary photos
  63. The Roles of FMRP-Regulated Genes in Autism Spectrum Disorder: Single- and Multiple-Hit Genetic Etiologies
  64. Abstract